Day: December 4, 2023
Cash Dividend Equates to 7.5% Yield on Current Share Price
NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE: SLG), Manhattan’s largest office landlord, announced today that its board of directors has established an annual ordinary dividend on SL Green’s common stock of $3.00 per share. The ordinary dividend will continue to be paid in cash on a monthly basis. The first monthly ordinary dividend of $0.25 per share is payable on January 16, 2024, to stockholders of record at the close of business on December 29, 2023.
“We believe that providing a sustainable, recurring dividend to our shareholders is a fundamental part of our business, while maintaining a focus on retained cash flow and distributing 100% of our taxable income. With the backdrop of a challenging, but improving, New York City office market...
Nayax Appoints New Chief Information Officer
Written by Customer Service on . Posted in Public Companies.
HERZLIYA, Israel, Dec. 04, 2023 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement, payments and loyalty platform designed to help merchants scale their business, today announced that Moshe Shmaryahu recently joined the Nayax leadership team as Chief Information Officer. Mr. Shmaryahu will lead the company’s information systems (IS) and Corporate IT, uniting the IT internal infrastructure and business applications under one roof to optimize the organization’s systems and technology.
Moshe Shmaryahu, who began serving as Nayax’s Chief Information Officer last month, served for 11 years prior to this as Chief Operating Officer (COO), Senior Director of Operations and Infrastructure at the Union Bank of Israel, the sixth largest Israeli bank. From 2009-2011, Mr. Shmaryahu served...
SL Green and Vornado Announce 270,000-Square-Foot Lease with a Premier Financial Services Tenant at 280 Park Avenue
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE: SLG), and Vornado Realty Trust (NYSE: VNO) today announced that they have signed a 15-year renewal and expansion lease with a premier financial services tenant covering 269,905 square feet on six floors at 280 Park Avenue. Spanning the entire block front of Park Avenue between 48th and 49th Streets, 280 Park Avenue is a best-in-class 1.25 million-square-foot Midtown Manhattan office building owned in joint venture between SL Green and Vornado.
“This lease together with the previously announced 100,000 square foot renewal and expansion lease with one of the world’s largest sovereign wealth funds reaffirms the strength of the Park Avenue submarket,” said Glen Weiss, Executive Vice President, Office Leasing – Co-Head of Real Estate at Vornado, and Steven...
SL Green and Vornado Announce 270,000-Square-Foot Lease with a Premier Financial Services Tenant at 280 Park Avenue
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE: SLG), and Vornado Realty Trust (NYSE: VNO) today announced that they have signed a 15-year renewal and expansion lease with a premier financial services tenant covering 269,905 square feet on six floors at 280 Park Avenue. Spanning the entire block front of Park Avenue between 48th and 49th Streets, 280 Park Avenue is a best-in-class 1.25 million-square-foot Midtown Manhattan office building owned in joint venture between SL Green and Vornado.
“This lease together with the previously announced 100,000 square foot renewal and expansion lease with one of the world’s largest sovereign wealth funds reaffirms the strength of the Park Avenue submarket,” said Glen Weiss, Executive Vice President, Office Leasing – Co-Head of Real Estate at Vornado, and Steven...
HEALWELL AI Completes Acquisition of ‘Pentavere’, a Leading Healthcare AI and Data Science Company
Written by Customer Service on . Posted in Mergers And Acquisitions.
HEALWELL completes acquisition of a majority stake of Pentavere, a healthcare artificial intelligence (AI) company who has built a best-in-class AI engine to help solve some of healthcare’s toughest data challenges. Pentavere has developed and validated leading capabilities in data structuring and abstraction; a key capability to unlocking clinical value and unmet needs for patients and providers.
The Pentavere acquisition adds revenue, new pharmaceutical and life sciences customers, access to hospitals as well as growing HEALWELL’s dedicated team of AI engineers.
The transaction is expected to be financially and strategically accretive and highly synergistic with HEALWELL’s strategic alliance agreement with WELL Health Technologies Corp. (“WELL”) (TSX: WELL).TORONTO, Dec. 04, 2023 (GLOBE NEWSWIRE) — HEALWELL AI Inc. (“HEALWELL”...
Fusion Fuel Green Hosts Third Quarter 2023 Investor Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
SABUGO, Portugal, Dec. 04, 2023 (GLOBE NEWSWIRE) — Fusion Fuel Green plc (NASDAQ: HTOO) (“Fusion Fuel”), an emerging leader in the green hydrogen sector, today announced financial results for the third quarter ended September 30, 2023. The quarterly shareholder letter is available at https://ir.fusion-fuel.eu/financials-filings/earnings-releases
Third Quarter 2023 HighlightsAnnounced long-term green hydrogen supply contract with a Spanish industrial group
Strategic partnership with Duferco Energia covering Italy, starting with a 1 MW HEVO-Chain Series NC project
In negotiations with BGR Energy to install 1 MW HEVO-Chain demonstrator in India in 2024
Announced strategic partnership with Elemental Clean Fuels covering the North American green hydrogen market
Received order for 300 kW electrolyzer and balance of...
Nexstim Releases New System Functionalities for Research Use in Europe
Written by Customer Service on . Posted in Public Companies.
Press release, Helsinki, 4 December 2023 at 10 AM (EET)
Nexstim Releases New System Functionalities for Research Use in Europe
Nexstim Plc (NXTMH:HEX) (“Nexstim” or “Company”) has delivered its first research system module as part of Nexstim NBS (Navigated Brain Stimulation) System 5 with the new functionalities of paired pulse delivery and an EEG user interface. As the new module option is for research use only, it is not CE-marked or FDA cleared but can be used with a customer’s latest versions of NBS System 5 in Europe.
The two new product options are called the NBR and TMS-EEG modules. The NBR software enables the delivery of paired pulses, which consist of two biphasic pulses delivered with a short interstimulus interval. Paired pulses can be configured during stimulation mode within the NBR software and stimulation...
Prosafe SE: Commencement of the subscription period in the subsequent offering
Written by Customer Service on . Posted in Public Companies.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA, JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.
Reference is made to the stock exchange announcement by Prosafe SE (the “Company” or “Prosafe”) on 29 November 2023 announcing the submission of a prospectus dated 29 November 2023 (the “Prospectus”) and the subsequent offering (the “Subsequent Offering”) of up to 1 333 333 new shares (the “Offer Shares”) in the Company, at a subscription price of NOK 60 per share.
The subscription period in the Subsequent Offering commences today, on 4 December 2023 at 09:00 hours (CET), and ends on 15 December 2023 at 16:30 hours (CET).
The Subsequent...
Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors
Written by Customer Service on . Posted in Public Companies.
Novel ultra-high affinity ligand OncoFAP targets Fibroblast Activation Protein (FAP), associated with a variety of solid tumors
Licensing agreement between Philochem and Blue Earth Diagnostics, one of the Bracco family of companies, encompasses applications of OncoFAP for diagnostic and medical imaging
Philogen’s Phase I clinical trial with investigational 68Ga-OncoFAP is underway in Europe, with first three patients successfully imaged
Blue Earth Diagnostics will assume further clinical development and future commercialization activities of OncoFAP for diagnostic or medical imaging purposes worldwideZURICH, Switzerland and OXFORD, United Kingdom and MONROE TOWNSHIP, N.J., Dec. 04, 2023 (GLOBE NEWSWIRE) — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco company and recognized...
NOVONIX Announces Participation in December Investor Events
Written by Customer Service on . Posted in Public Companies.
BRISBANE, Australia, Dec. 04, 2023 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), a leading battery materials and technology company, today announced that members of the executive team are scheduled to participate in the following upcoming investor events in December 2023:Janney Montgomery Scott Clean Energy Investment Symposium to be held December 5th-6th in New Orleans, LA;
Chardan’s Battery Technology Virtual Conference Series to be broadcast Monday, December 11th; and
Bank of America Battery Tech Mini-Conference with NOVONIX presenting virtually on Tuesday, December 12th at 11:45 am ESTNOVONIX management will be available to host one-on-one and group investor meetings during the conferences. Presentation materials and available webcast links will be available prior to each event...